HOME >> MEDICINE >> NEWS
Temple University Hospital investigates treatment for cervical dysplasia

PHILADELPHIA -- Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.

For numerous women afflicted with the common sexually transmitted disease known as human papillomavirus (HPV), the immune system can not prevent certain high-risk strains of the virus from causing cervical dysplasia, a common precursor to cervical cancer. "The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer," said Enrigue Hernandez, The Abraham Roth Professor and Chair of the Department of Obstetrics and Gynecology at Temple University Hospital and School of Medicine. "However, for those women already infected with HPV, and those who will become infected, there are emerging non-surgical options in development."

HPV vaccines are expected to be a significant advance in women's healthcare, but they will not protect all women from cervical cancer. "Prophylactic vaccines will probably not help the more than 350,000 women in the U.S. already infected with HPV who have moderate to severe cervical dysplasia, a precancerous condition," explained Hernandez.

Amolimogene is an investigational immunotherapeutic from MGI PHARMA, Inc. that is currently being evaluated in a pivotal phase 2 clinical program in multiple centers in the U.S., including Philadelphia. "This product candidate is designed to enhance the body's immune response to cervical dysplasia, and is being developed to offer patients with cervical dysplasia and healthcare providers an option to surgical intervention," explained Hernandez. "Qualified participants must be 25 or younger, with an abnormal Pap te
'"/>

Contact: Vivica Aycox
vaycox@temple.edu
215-707-7790
Temple University Health System
30-Jan-2007


Page: 1 2

Related medicine news :

1. NIH awards $1 million to Temple University Hospital for neurological treatment studies
2. UPenn receives 2005 Templeton Research Lectures Grant
3. Indiana University Imaging Center receives $6M grant for kidney research
4. University hospitals wins multiple national IT awards for electronic patient data bank
5. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
6. University research wins royal accolade
7. New Orleans levee report finished by panel including University of Texas at Austin engineer
8. Boston University School of Medicine faculty member receives honorary degree from alma mater
9. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
10. Emory University researchers find persistent and severe asthma associated with obesity
11. Mid Sweden University leads development of digital color x-rays

Post Your Comments:
(Date:2/26/2015)... NJ (PRWEB) February 26, 2015 A ... The practice is offering the following 50 year ... $90 for their choice of Sonic Care Diamond Clean ... $199, $179 respectively). The cost is $2895 for ... that require more than ten treatment procedures are priced ...
(Date:2/26/2015)... Scotch Plains, NJ (PRWEB) February 26, 2015 ... a “NJ Top Dentist” for Dr. David Caggiano! ... education, experience and interests. Combining his background in ... seven years of experience as a general dentist allows ... the toughest orthodontic situations. He was named Orthodontic ...
(Date:2/26/2015)... The hip resurfacing procedure at Texas ... resident John Short to resume his active lifestyle, it has ... climb Mt. Kilimanjaro, the highest free-standing mountain in the world, ... in his late 20s, Short suffered from early onset degeneration. ... sockets were bone on bone. , Then about five ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Beckman ... “Diversity of extracellular vesicles and their cargo in cell-to-cell ... vesicles and their relevance for cell-to-cell communication. The webinar ... March 4, 2015 at 8:00am PT. , Every cell ... extracellular vesicles (EVs) , often called “exosomes” or “microvesicles.” ...
(Date:2/26/2015)... 2015 2015 Deep Market Research ... and in-depth study on the current state of ... focus on the Chinese situation. , Major companies ... & Co.KG, Hu-Friedy, Medisporex, Towne Brothers, Teleflex Medical, ... Weirong Medical Equipment, Shuanglu, Changshu Henry Medical Instrument, ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3
(Date:2/26/2015)... Editor Note: For more ... Investor-Edge has initiated coverage on the following ... Teva Pharmaceutical Industries Ltd (NYSE: TEVA ), ... Inc. (NYSE: AGN ), and Depomed Inc. ... Johnson and Johnson can be accessed at http://get.Investor-Edge.com/pdf/?c=Johnson%20and%20Johnson&d=26-Feb-2015&s=JNJ ...
(Date:2/26/2015)... , Feb. 26, 2015  MEI Pharma, Inc. (Nasdaq: ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the Cowen and Company 35 th ... at 10:40 a.m. Eastern time from the Boston Marriott Copley ... at www.meipharma.com . A replay will be available approximately ...
(Date:2/26/2015)... CITY , Feb. 26, 2015  Great Basin ... launched a "best efforts" follow-on offering of up to ... of one share of Series E preferred stock and ... preferred stock will be convertible into four shares of ... exercisable into one share of common stock at an ...
Breaking Medicine Technology:Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
Cached News: